This exploration was carried out To judge the prospective in the CPPs with tumor-concentrating on Qualities to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic method for CXCR4+ HCC cells. T